Minoo Niknian

2.6k total citations · 1 hit paper
22 papers, 2.1k citations indexed

About

Minoo Niknian is a scholar working on Public Health, Environmental and Occupational Health, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minoo Niknian has authored 22 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Dermatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minoo Niknian's work include Menstrual Health and Disorders (4 papers), Acne and Rosacea Treatments and Effects (4 papers) and Cystic Fibrosis Research Advances (4 papers). Minoo Niknian is often cited by papers focused on Menstrual Health and Disorders (4 papers), Acne and Rosacea Treatments and Effects (4 papers) and Cystic Fibrosis Research Advances (4 papers). Minoo Niknian collaborates with scholars based in United States, Germany and Australia. Minoo Niknian's co-authors include Thomas M. Lasater, Richard A. Carleton, Paul Körner, Carole Sampson-Landers, Joachim Marr, William Rakowski, Laura Linnan, Sonja M. McKinlay, Bryan F. J. Manly and R. Craig Lefebvre and has published in prestigious journals such as Technometrics, PEDIATRICS and American Journal of Public Health.

In The Last Decade

Minoo Niknian

22 papers receiving 2.0k citations

Hit Papers

Permutation Tests: A Practical Guide to Resampling Method... 1995 2026 2005 2015 1995 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoo Niknian United States 17 281 225 178 176 176 22 2.1k
Phillip Good Australia 31 291 1.0× 944 4.2× 237 1.3× 144 0.8× 283 1.6× 143 3.6k
Sonja Greven Germany 25 179 0.6× 100 0.4× 141 0.8× 84 0.5× 836 4.8× 64 2.6k
Marta García‐Fiñana United Kingdom 28 181 0.6× 371 1.6× 592 3.3× 168 1.0× 69 0.4× 100 2.9k
Potter C. Chang United States 18 115 0.4× 119 0.5× 278 1.6× 313 1.8× 342 1.9× 35 3.4k
Joachim Härtung Germany 19 167 0.6× 215 1.0× 155 0.9× 214 1.2× 589 3.3× 51 3.6k
Michael Larsen United States 24 63 0.2× 137 0.6× 75 0.4× 62 0.4× 293 1.7× 110 2.6k
Peter Dalgaard Denmark 20 478 1.7× 83 0.4× 73 0.4× 135 0.8× 88 0.5× 38 3.1k
Valentin Amrhein Switzerland 28 148 0.5× 157 0.7× 128 0.7× 67 0.4× 280 1.6× 64 3.8k
Fabian Scheipl Germany 19 163 0.6× 55 0.2× 59 0.3× 136 0.8× 497 2.8× 43 1.8k
Joyce Shaffer United States 8 208 0.7× 123 0.5× 128 0.7× 39 0.2× 208 1.2× 10 1.6k

Countries citing papers authored by Minoo Niknian

Since Specialization
Citations

This map shows the geographic impact of Minoo Niknian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoo Niknian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoo Niknian more than expected).

Fields of papers citing papers by Minoo Niknian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoo Niknian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoo Niknian. The network helps show where Minoo Niknian may publish in the future.

Co-authorship network of co-authors of Minoo Niknian

This figure shows the co-authorship network connecting the top 25 collaborators of Minoo Niknian. A scholar is included among the top collaborators of Minoo Niknian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoo Niknian. Minoo Niknian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flume, Patrick A., Claire Wainwright, D. Elizabeth Tullis, et al.. (2017). Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor. Journal of Cystic Fibrosis. 17(1). 83–88. 37 indexed citations
2.
Stalvey, Michael S., et al.. (2017). Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor. PEDIATRICS. 139(2). 45 indexed citations
3.
Landrum, Michael L., Tahaniyat Lalani, Minoo Niknian, et al.. (2016). Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults. Human Vaccines & Immunotherapeutics. 13(4). 791–801. 23 indexed citations
4.
Stalvey, Michael S., et al.. (2016). 197 Ivacaftor improves linear growth in children with cystic fibrosis (CF) and a G551D-CTFR mutation: data from the ENVISION study. Journal of Cystic Fibrosis. 15. S101–S101. 2 indexed citations
5.
Taylor‐Cousar, Jennifer L., Minoo Niknian, Geoffrey Gilmartin, & Joseph M. Pilewski. (2015). Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States. Journal of Cystic Fibrosis. 15(1). 116–122. 41 indexed citations
6.
Hatsukami, Dorothy K., Douglas E. Jorenby, David Gonzales, et al.. (2011). Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic. Clinical Pharmacology & Therapeutics. 89(3). 392–399. 144 indexed citations
9.
Maloney, Jennifer, Peter Dietze, David Watson, et al.. (2008). Treatment of Acne Using a 3-Milligram Drospirenone/20-Microgram Ethinyl Estradiol Oral Contraceptive Administered in a 24/4 Regimen. Obstetrics and Gynecology. 112(4). 773–781. 54 indexed citations
10.
Lucky, Anne W., William Koltun, Diane Thiboutot, et al.. (2008). A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.. PubMed. 82(2). 143–50. 23 indexed citations
11.
Borenstein, Jeff, Kathleen W. Wyrwich, Minoo Niknian, et al.. (2006). Determining Clinically Meaningful Benefit in the Treatment of Premenstrual Dysphoric Disorder. Obstetrics and Gynecology. 107(Supplement). 15S–16S. 4 indexed citations
12.
Feldman, Henry A., Sonja M. McKinlay, & Minoo Niknian. (1996). Batch Sampling To Improve Power in a Community Trial. Evaluation Review. 20(3). 244–274. 14 indexed citations
13.
Niknian, Minoo, et al.. (1995). Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. Technometrics. 37(3). 341–341. 1158 indexed citations breakdown →
14.
Niknian, Minoo. (1995). Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. Technometrics. 37(3). 341–342. 195 indexed citations
15.
Niknian, Minoo. (1993). Randomization and Monte Carlo Methods in Biology. Technometrics. 35(1). 96–97. 26 indexed citations
16.
Niknian, Minoo & Bryan F. J. Manly. (1993). Randomization and Monte Carlo Methods in Biology. Technometrics. 35(1). 96–96. 27 indexed citations
17.
Niknian, Minoo, Laura Linnan, Thomas M. Lasater, & Richard A. Carleton. (1991). Use of Population-Based Data to Assess Risk Factor Profiles of Blue and White Collar Workers. Journal of Occupational and Environmental Medicine. 33(1). 29–36. 55 indexed citations
18.
Niknian, Minoo, et al.. (1991). Are people more health conscious? A longitudinal study of one community.. American Journal of Public Health. 81(2). 205–207. 14 indexed citations
19.
Niknian, Minoo, et al.. (1989). A comparison of perceived and objective CVD risk in a general population.. American Journal of Public Health. 79(12). 1653–1654. 38 indexed citations
20.
Nelson, Deborah J., Thomas M. Lasater, Minoo Niknian, & Richard A. Carleton. (1989). Cost effectiveness of different recruitment strategies for self-help smoking cessation programs. Health Education Research. 4(1). 79–85. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026